am I the only one who found triple agonist harder than the injections
Slightly embarrassed to be asking this, but: am I the only one who found triple agonist harder than the injections. Stopped at a low step because there was no reason to go further and no data to tell me what further would do. The standing caveat, written out properly because it keeps getting compressed into a…
Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.
Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.
Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.
Are you comparing against phase 3 numbers for something else? They are not comparable.
Disagree. "More receptors means more effect" is not how any of this works and the trial data does not support the linear story.
Disagree.
blunt_coldbox_2024 is right about the escalation being the variable. It explains most of the difficult reports here.
That is body weight change, not fat mass. The trials report the first and people quote it as the second.
Yes — the comparison threads are apples to oranges and they generate more heat than anything else here.
research-use-only material is not approved for human use, full stop
not approved anywhere, which is the single most important fact in this board